Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114779) titled 'A randomized, controlled, open-label cohort clinical study to evaluate the incidence of radiation pneumonitis six months after treatment with valsartan combined with thoracic radiotherapy and immune checkpoint inhibitors versus thoracic radiotherapy and immune checkpoint inhibitors alone' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Jinan central hospital
Condition:
Lung cancer
Intervention:
Valsartan combined with chest radiotherapy combined with immune checkpoint inhibitors:1. For the first round of chest radiotherapy combined with immunotherapy, start oral v...